Is Atropine Sulfate Injection in shortage?
Yes. Atropine Sulfate Injection is on FDA’s drug shortage list (unavailable), last updated Oct 5, 2026.
Why it’s in shortage
- Discontinuation of the manufacture of the drug
- Other
- Requirements related to complying with good manufacturing practices
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)
Maker contact: 800-423-4136
- Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)
Discontinuation of the manufacture of the drug
Maker contact: 866-941-7875, option 2
- Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)
Maker contact: 866-941-7875, option 2
- Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)
Discontinuation of the manufacture of the drug
Maker contact: 866-941-7875, option 2
- Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)
Maker contact: 800-645-1706
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)
Maker contact: 800-645-1706
- Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)
Maker contact: 844-646-4398
- Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)
Maker contact: 800-631-2174
- Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)
Maker contact: 630-682-4600
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)
Maker contact: 732-554-1037
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)
Maker contact: 732-554-1037
- Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)
Maker contact: 732-554-1037
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)
Estimated recovery: TBD
Maker contact: 866-941-7875, option 2
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)
Estimated recovery: mid-September 2026
Maker contact: 866-941-7875, option 2
- Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)
Estimated recovery: TBD
Maker contact: 866-941-7875, option 2
- Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)
Check wholesalers for inventory
Maker contact: 888-386-1300
- Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)
Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)"
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
- Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)"
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
FDA recalls of Atropine Sulfate
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Atropine Sulfate Injection:
- SOMERSET THERAPEUTICS LLC recalls Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC.
- Pfizer Inc. recalls Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL
- Accord Healthcare, Inc. recalls Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials, Rx only, Manufactured for:
- Mckesson Medical-Surgical Inc. Corporate Office recalls Isopto Atropine (atropine sulfate ophthalmic solution) 1%, 5mL bottle, MFG: Alcon Surgical, NDC 0065-0303-55
- Pfizer Inc. recalls diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1),
- Rx PAK recalls Donnatal (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide) tablets, 100-count bottle, Rx
Atropine Sulfate Injection shortage questions
Is Atropine Sulfate Injection in shortage?
Yes. Atropine Sulfate Injection is on FDA’s drug shortage list (unavailable), last updated Oct 5, 2026.
Why is there a Atropine Sulfate Injection shortage?
FDA records the reason as: Discontinuation of the manufacture of the drug; Other; Requirements related to complying with good manufacturing practices.
What should I do if I can’t get Atropine Sulfate Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.